Invesco
IGMS

Invesco’s IGM Biosciences IGMS Stock Holding History

Invesco’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,127
Closed -$41.5K – 3803
2025
Q1 		$41.5K Buy
+36,127
New +$67.2K ﹤0.01% 3712
2024
Q4 		– Sell
-222,928
Closed -$3.69M – 3783
2024
Q3 		$3.69M Buy
+222,928
New +$2.44M ﹤0.01% 2381
2023
Q3 		– Sell
-11,312
Closed -$104K – 3888
2023
Q2 		$104K Buy
11,312
+822
+8% +$9.21K ﹤0.01% 3718
2023
Q1 		$144K Buy
+10,490
New +$217K ﹤0.01% 3671
2021
Q4 		– Sell
-4,582
Closed -$301K – 4065
2021
Q3 		$301K Buy
4,582
+418
+10% +$32K ﹤0.01% 3653
2021
Q2 		$346K Buy
+4,164
New +$308K ﹤0.01% 3568

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Invesco's IGMS Position: Q2 2025 in Review

Invesco sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 36,127 shares — an estimated $41.5K sold.

Invesco first reported a position in IGMS in Q2 2021 and held it in 6 quarters. The position peaked at $3.69M in Q3 2024. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Invesco reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 36,127 IGM Biosciences shares in Q2 2025, an estimated $41.5K.
  • Invesco first reported a position in IGM Biosciences in Q2 2021 and held it in 6 quarters.
  • Invesco's IGM Biosciences position peaked at $3.69M in Q3 2024.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.